Yehiel Tal

CEO, Collplant Biotechnologies

Search every verified Yehiel Tal interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a March 2021 podcast interview, Yehiel Tal, CEO of CollPlant Biotechnologies, discussed the company's recombinant human collagen (rhCollagen) technology platform. Tal stated that the company's collagen is "produced in plants" and is "virgin recombinant human collagen" that "does not elicit an immune response," which he described as important for making large constructs for transplants. He also defined scientific innovation as being effective when properly planned. Tal described several operational changes at CollPlant during the COVID-19 pandemic. He said the company decided to pay full salaries to all employees, which he said motivated staff and contributed to the company. He also noted that the company adopted remote work, enhanced its use of social media for investor and collaborator positioning, and used platforms like LinkedIn and virtual university events for recruitment. Tal advised other CEOs to plan ahead, build flexible company structures, and maintain multiple suppliers and strategic collaborators for critical items.